View Author
patient blood number cancer level t cells therapy treatment blood samples sample t-cell lymphocytes cytokine infusion flow cytometry immunogene therapy detection plasma receptor cytometry assay lamer rcc cells method panel production transduced immunol cycle percentage result cytokine production variation patient 2 rcc patients t lymphocytes patient 1 tumor transduced t cells activity liver toxicity clone immunogene patient 3 function transfer cell cancer rosenberg staining autologou administration gene-modified t cells liver g 250 mab nuh 821 cells metastatic plasma cytokine levels cytometric chain sensitivity 0.1 fg cytolysis gene-modified target willemsen study dudley cell transfer therapy control il -10 nuh 82 mab expression toxicity k 562 targets event plasma ifn il -2 administrations polymerase chain reaction flow cytometric method interleukin
3 Most Recent Publications
|
Gene-modified T cells for adoptive immunotherapy of renal cell cancer maintain transgene-specific immune functions in vivo
(Article)
Lamers, C.H.J. Langeveld, S.C.L. Groot-van Ruijven, C.M. Debets, J.E.M.A. Sleijfer, S. Gratama, J-W. |
2007-12-01
|
|
Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient’s T lymphocytes using a carboxy anhydrase IX-specific scFv transgene
(Article)
Lamers, C.H.J. Elzakker, P.M.M.L. van Langeveld, S.C.L. Sleijfer, S. Gratama, J-W. |
2006-12-01
|
|
Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression
(Article)
Lamers, C.H.J. Gratama, J-W. Pouw, N.M.C. Langeveld, S.C.L. Krimpen, B.A. van Kraan, J. Stoter, G. Debets, J.E.M.A. |
2005-12-01
|